Position
Fidelity in 10x Genomics, Inc.
Back to the book · All holders of TXG
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $301.6M$21.23 → $38.34
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 11.9M | $194.4M | — | — | — | 0.0% |
| Q1 2026 | 17.7M | $376.6M | $21.23 | $58.6M | $123.6M | 0.0% |
| Q2 2026 | 17.6M | $675.9M | $38.34 | $301.6M | −$2.37M | 0.0% |